Abiomed (ABMD)'s Impella® Technology Showcased atAmerican College of Cardiology 2013  
3/7/2013 11:33:46 AM

DANVERS, Mass., March 7, 2013 (GLOBE NEWSWIRE) -- Abiomed Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, notes that there will be over 15 Impella presentations in the scientific sessions at the annual American College of Cardiology (ACC) 2013 scientific meeting, scheduled from March 9 - 11, at the Moscone Convention Center in San Francisco.